NFKB1 and breast cancer: Both the canonical and non-canonical NFκB signalling pathways play a role in breast cancer bone metastasis [10], and we have previously reported that the small-molecule inhibitors of these pathways, Celastrol and Parthenolide, reduced the development of osteolysis in a rat model of breast cancer-induced osteolysis [22].